SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-004669
Filing Date
2021-02-12
Accepted
2021-02-12 16:44:02
Documents
18
Period of Report
2021-02-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nt10020123x6_8k.htm   iXBRL 8-K 43004
2 EXHIBIT 1.1 nt10020123x6_ex1-1.htm EX-1.1 231748
3 EXHIBIT 5.1 nt10020123x6_ex5-1.htm EX-5.1 12508
4 EXHIBIT 99.1 nt10020123x6_ex99-1.htm EX-99.1 12675
5 EXHIBIT 99.2 nt10020123x6_ex99-2.htm EX-99.2 12374
9 image0.jpg GRAPHIC 160425
10 image00002.jpg GRAPHIC 19460
  Complete submission text file 0001140361-21-004669.txt   777932

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA infi-20210211.xsd EX-101.SCH 4183
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE infi-20210211_lab.xml EX-101.LAB 22718
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE infi-20210211_pre.xml EX-101.PRE 16208
11 EXTRACTED XBRL INSTANCE DOCUMENT nt10020123x6_8k_htm.xml XML 4237
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 21628640
SIC: 2834 Pharmaceutical Preparations